AVITA Medical, Inc. (RCEL) Cash Flow Statement
AVITA Medical, Inc. (RCEL) generated -$24.2M of operating cash flow over the twelve months to 2026-06-30, spent $1.0M on capital expenditure and had free cash flow of -$25.2M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RCELAVITA Medical, Inc.Follow RCEL — free
—
Price chart with a free account
- Market cap
- 479.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 11 days
| Line | FY2020 Jun 20 | FY2021 Jun 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -22.7 | -25.9 | -19.1 | -38.0 | -48.9 | -31.2 | -24.2 | |
| Capital expenditure | 0.6 | 0.9 | 0.5 | 1.4 | 9.2 | 1.6 | -1.0 | |
| Free cash flow | -23.3 | -26.8 | -19.5 | -39.4 | -58.1 | -32.8 | -25.2 | |
| Stock-based compensation | 16.5 | 5.7 | 7.0 | 8.4 | 13.5 | 9.5 | — |
USD millions · SEC XBRL
AVITA Medical, Inc. — questions
- What is AVITA Medical, Inc.'s operating cash flow?
- -$24.2M over the twelve months to 2026-06-30.
- How much does AVITA Medical, Inc. spend on capital expenditure?
- $1.0M over the twelve months to 2026-06-30.
- What is AVITA Medical, Inc.'s free cash flow?
- -$25.2M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from AVITA Medical, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.